Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × Sirolimus × Clear all

NCT03099356 2025-08-01

Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

Phase 2 Recruiting

Thyroid Neoplasms